Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02345265
Title Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

endometrioid ovary carcinoma

ovarian endometrial cancer

ovarian serous cystadenocarcinoma

fallopian tube endometrioid adenocarcinoma

peritoneal serous adenocarcinoma

ovary serous adenocarcinoma

fallopian tube serous adenocarcinoma

Therapies

Cediranib + Olaparib

Age Groups: adult senior


No variant requirements are available.